Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 7/20 | 0.42 |
| ▸ | ACE | P12821 | 8/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.37 |
| ▸ | F2 | P00734 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL7430652 | 0.97 | DPP4 (0.40) | DPP4ACEACE2F2 | |
| SCHEMBL9218974 | 0.91 | DPP4 (0.44) | DPP4ACEACE2F2 | |
| SCHEMBL7444009 | 0.90 | DPP4 (0.42) | DPP4ACEACE2F2 | |
| Hydrochloric Acid SCHEMBL7415872 | 0.89 | DPP4 (0.41) | DPP4ACEACE2F2 | |
| SCHEMBL7106838 | 0.89 | ACE (0.39) | DPP4ACEACE2F2 | |
| Sulfuric Acid SCHEMBL7436108 | 0.86 | ACE (0.37) | DPP4ACEACE2F2 | |
| Sulfuric Acid SCHEMBL9554342 | 0.85 | DPP4 (0.37) | DPP4ACEACE2F2 | |
| SCHEMBL9221310 | 0.84 | DPP4 (0.38) | DPP4ACEF2 | |
| SCHEMBL9226805 | 0.82 | DPP4 (0.38) | DPP4ACEF2 | |
| SCHEMBL9223278 | 0.81 | DPP4 (0.33) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0684258-A2 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-11-29 | — | — | EP | claimed |
| US-5430023-A | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-07-04 | — | — | US | claimed |
| EP-0479489-A2 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1992-04-08 | — | — | EP | claimed |
| EP-0685489-B1 | Tripeptide antithrombotic agents | LILLY CO ELI (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-0837071-A1 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1998-04-22 | — | — | EP | disclosed |
| EP-0685489-A2 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-12-06 | — | — | EP | disclosed |
| EP-0684258-A2 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-11-29 | — | — | EP | disclosed |
| US-5430023-A | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-07-04 | — | — | US | disclosed |
| US-5250660-A | Peptide purification process | ELI LILLY AND COMPANY (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0479489-A2 | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1992-04-08 | — | — | EP | disclosed |